Unbound MEDLINE

Comparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemic in mice. Prostaglandins & other lipid mediators [Prostaglandins Other Lipid Mediat] Journal article

 
TitleComparison of microsomal prostaglandin E synthase-1 deletion and COX-2 inhibition in acute cardiac ischemic in mice.
Author(s)Wu D, Mennerich D, Arndt K, Sugiyama K, Ozaki N, Schwarz K, Wei J, Wu H, Bishopric NH, Doods H 
InstitutionDepartment of Research, Division of Neonatology, Mount Sinai Medical Center, Miami Beach, FL, 33140, USA.
SourceProstaglandins Other Lipid Mediat 2009 Jun 24.
AbstractThe aim of the present study was to compare the effects of genetic mPGES-1 loss and COX-2 inhibition on myocardial damage after coronary occlusion. mPGES-1(-/-) mice and their wild type littermates were injected with vehicle or COX-2 inhibitor (celecoxib), and 30min later the left coronary artery was surgically occluded. At 24h, myocardial infarct (MI) volume was measured histologically. Post-MI survival was reduced in WT mice receiving celecoxib (12/20) compared with vehicle-treated controls (12/12) or the loss of mPGES-1 (13/13) together with increased phosphokinase (CPK) and cardiac troponin-I release. Endogenous mPGES-1 expression was unchanged by ischemia in WT mice and absent in mPGES-1(-/-) hearts. COX-2 expression was markedly increased at 24hours after MI in WT hearts; this up-regulation was largely attenuated in mPGES-1(-/-) mice. We conclude that Loss of mPGES-1 prevents the upregulation of COX-2 after myocardial infarct, and in contrast to inhibition of COX-2, does not increase ischemic myocardial damage.
LanguageENG
Pub Type(s)JOURNAL ARTICLE
PubMed ID19559811
  
Advertise on this site.